Back to search
FDAFDA · Food and drugs·Recall number D-0833-2026

Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.

Published September 9, 2026 · Recall initiated: August 31, 2026

Summary

FDA records drug Class III recall D-0833-2026, published September 9, 2026 and initiated August 31, 2026. Recalling firm: Supernus Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 11304 bottles; Lot: Lot# 2145283, Exp Date: 31-Mar-2030. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications.

What to do

Voluntary: Firm initiated

Get an email if TROKENDI XR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TROKENDI XR
Manufacturer
Supernus Pharmaceuticals, Inc.
Distributor
US Nationwide.
UPC
0317772101300
Lot
Lot# 2145283, Exp Date: 31-Mar-2030.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30. recalled?

Yes. FDA published recall D-0833-2026 on September 9, 2026. Reported hazard: Failed dissolution specifications.

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TROKENDI XR. UPC: 0317772101300.